Palvella Therapeutics, Inc.
PVLA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $64 | $70 | $76 | $84 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $2 | $2 | $2 | $2 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $1 | $2 | $2 |
| Total Curr. Assets | $67 | $74 | $79 | $88 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $67 | $74 | $79 | $88 |
| Liabilities | – | – | – | – |
| Payables | $3 | $5 | $4 | $5 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $7 | $5 | $5 | $7 |
| Total Curr. Liab. | $10 | $10 | $9 | $12 |
| LT Debt | $0 | $15 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $18 | $2 | $15 | $14 |
| Total NC Liab. | $18 | $16 | $15 | $14 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $28 | $26 | $24 | $26 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$123 | -$111 | -$102 | -$94 |
| AOCI | $0 | -$0 | -$0 | $0 |
| Other Equity | $161 | $159 | $157 | $156 |
| Total Equity | $39 | $48 | $56 | $63 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $67 | $74 | $79 | $88 |
| Net Debt | -$64 | -$56 | -$76 | -$84 |